Effectiveness and quality of life in asthmatic patients treated with budesonide/formoterol via Elpenhaler® device in primary care. The “SKIRON” real world study-Reference-Cited by-同舟云学术

Effectiveness and quality of life in asthmatic patients treated with budesonide/formoterol via Elpenhaler® device in primary care. The “SKIRON” real world study

Published:2022-10-17 Issue:6 Volume:60 Page:1104-1114
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Steiropoulos Paschalis¹,Exarchos Konstantinos²^ORCID,Bertoli Maria³,Karakontaki Foteini⁴,Antonogiannakis Georgios⁵,Polychronopoulos Vlassios⁴,Gogali Athena²^ORCID,Kostikas Konstantinos²^ORCID

Affiliation:

1. Department of Pulmonology, University General Hospital of Alexandroupolis, Alexandroupoli, Greece

2. Respiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece

3. Medical Department, ELPEN Pharmaceutical Co. Inc, Pikermi, Attica

4. Pulmonary Clinic, Hygeia Hospital, Marousi, Athens

5. Primary Healthcare Center of Moires, Heraklion, Greece

Funder

ELPEN Pharmaceutical Co. Inc.

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2022.2132957

Reference41 articles.

1. 2021 GINA Report. Global Strategy for Asthma Management and Prevention. 2021.

2. Risk factors for asthma: is prevention possible?

3. Estudio de los mecanismos implicados en la génesis y evolución del asma (proyecto MEGA): creación y seguimiento a largo plazo de una cohorte de pacientes asmáticos

4. Asthma

5. Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study